MicroRNAs as potential cancer therapeutics

被引：159

作者：

Trang P. ^{[1
,2
]}

Weidhaas J.B. ^{[2
]}

Slack F.J. ^{[1
]}

机构：

[1] Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT

[2] Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT

来源：

Oncogene | 2008年 / 27卷 / Suppl 2期

关键词：

Cancer; MicroRNAs; Profiling; Therapeutic; Tumor suppressor;

D O I：

10.1038/onc.2009.353

中图分类号：

学科分类号：

摘要：

MicroRNAs (miRNAs) have been shown to have an important role in various cellular processes, such as apoptosis, differentiation and development. Recent studies have shown that miRNAs are mis-expressed in human cancers where they can exert their effect as oncogenes or tumor suppressors. Here, we review the potential for using miRNAs as biomarkers for diagnosis, prognosis and cancer therapies. © 2009 Macmillan Publishers Limited. All rights reserved.

引用

页码：S52 / S57

页数：5

共 67 条

[1]

Bartel D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, pp. 281-297, (2004)

[2]

Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Et al., MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis, JAMA, 297, pp. 1901-1908, (2007)

[3]

Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., Et al., The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities, Nat Med, 14, pp. 1271-1277, (2008)

[4]

Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Et al., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proc Natl Acad Sci USA, 99, pp. 15524-15529, (2002)

[5]

Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Et al., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci USA, 101, pp. 2999-3004, (2004)

[6]

Chan J.A., Krichevsky A.M., Kosik K.S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, Cancer Res, 65, pp. 6029-6033, (2005)

[7]

Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Et al., Widespread microRNA repression by Myc contributes to tumorigenesis, Nat Genet, 40, pp. 43-50, (2008)

[8]

Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., Et al., A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk, Cancer Res, 68, pp. 8535-8540, (2008)

[9]

Christensen B.C., Moyer B.J., Avissar M., Ouellet L.G., Plaza S.L., McClean M.D., Et al., A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers, Carcinogenesis, 30, pp. 1003-1007, (2009)

[10]

Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Et al., Extensive modulation of a set of microRNAs in primary glioblastoma, Biochem Biophys Res Commun, 334, pp. 1351-1358, (2005)

← 1 2 3 4 5 6 7 →